Our round-up of letters published in the Ravalli Republic ...

On January 28, 2025, the Company received clearance of its IND from the FDA to initiate a first-in-human Phase 1 dose ...

China's leading auto insurance technology platform, today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2024.